Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -20 of 57 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/16/2008 First Published: 12/9/2005


11.		Phase III Randomized Study of Neoadjuvant Therapy Comprising Exemestane Versus Letrozole Versus Anastrozole in Postmenopausal Women With Estrogen Receptor Positive Stage II or III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Postmenopausal				NCI				ACOSOG-Z1031 CALGB-ACOSOG-Z1031, ACOSOG-Z1031, SDC1, NCT00265759

Last Modified: 10/16/2008 First Published: 3/24/2006


12.		Phase III Randomized Study of Adjuvant Combination Chemotherapy and Hormonal Therapy Versus Adjuvant Hormonal Therapy Alone in Women With Previously Resected Axillary Node-Negative Breast Cancer With Various Levels of Risk for Recurrence (TAILORx Trial)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 75				NCI				ECOG-PACCT-1 SWOG-ECOG-PACCT-1, CALGB-ECOG-PACCT-1, NCCTG-ECOG-PACCT-1, NSABP-ECOG-PACCT-1, ACOSOG-ECOG-PACCT-1, CAN-NCIC-MAC12, PACCT-1, NCT00310180, TAILORx


13.		Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 80				Pharmaceutical / Industry				CFEM345EGB07 NCT00330317


14.		Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Pharmaceutical / Industry				CFEM345DDE09 NCT00332709


15.		Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Pharmaceutical / Industry				CFEM345DDE10 NCT00332852

Last Modified: 10/16/2008 First Published: 9/23/2006


16.		Phase III Randomized Study of Letrozole in Postmenopausal Women With Hormone Receptor-Positive Breast Cancer Who Have Completed Adjuvant Hormonal Therapy Comprising An Aromatase Inhibitor and/or Tamoxifen Citrate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Any age (postmenopausal)				NCI				NSABP-B-42 NSABP-B-42, NCT00382070

Last Modified: 11/29/2006 First Published: 11/17/2006


17.		Phase III Randomized Study of Chemotherapy and Endocrine Therapy as First-Line Treatment for Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 75				Other				KRDI-TUM-CORE-GYN-040-380-21260 EU-20660, EUDRACT-2005-000986-20, KRDI-TUM-COR-259-PAE-0100-I, NCT00403182

Last Modified: 6/18/2008 First Published: 2/5/2007


18.		Phase III Randomized Study of 70-Gene Signature Versus Clinical Assessment in Selecting Women With Node-Negative Breast Cancer for Adjuvant Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Other, Pharmaceutical / Industry				EORTC-10041 EUDRACT-2005-002625-31, BIG-3-04, NOVARTIS-EORTC-10041, ROCHE-EORTC-10041, SANOFI-AVENTIS-EORTC-10041, NCT00433589


19.		HOBOE: A Study of Hormonal Adjuvant Treatment Effect on Bone Mineral Density in Early Breast Cancer Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Active				18 and over				Other				HOBOE NCT00412022


20.		Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Behavioral study, Supportive care, Treatment				Active				Not specified				Other				OCOG-2007-LISA NCT00463489

Select All on One Page


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute